| Adamantane–a lead structure for drugs in clinical practice K Spilovska, F Zemek, J Korabecny, E Nepovimova, O Soukup, ... Current medicinal chemistry 23 (29), 3245-3266, 2016 | 206 | 2016 |
| Synthesis and biological evaluation of novel tacrine derivatives and tacrine–coumarin hybrids as cholinesterase inhibitors S Hamulakova, L Janovec, M Hrabinova, K Spilovska, J Korabecny, ... Journal of medicinal chemistry 57 (16), 7073-7084, 2014 | 124 | 2014 |
| 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies J Korabecny, R Dolezal, P Cabelova, A Horova, E Hruba, J Ricny, ... European journal of medicinal chemistry 82, 426-438, 2014 | 96 | 2014 |
| 7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer’s disease treatment—synthesis, biological evaluation and molecular modeling studies K Spilovska, J Korabecny, J Kral, A Horova, K Musilek, O Soukup, ... Molecules 18 (2), 2397-2418, 2013 | 94 | 2013 |
| Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer’s Disease K Spilovska, J Korabecny, E Nepovimova, R Dolezal, E Mezeiova, ... Current topics in medicinal chemistry 17 (9), 1006-1026, 2017 | 91 | 2017 |
| From pyridinium-based to centrally active acetylcholinesterase reactivators J Korabecny, O Soukup, R Dolezal, K Spilovska, E Nepovimova, M Andrs, ... Mini reviews in medicinal chemistry 14 (3), 215-221, 2014 | 72 | 2014 |
| Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation K Spilovska, J Korabecny, V Sepsova, D Jun, M Hrabinova, P Jost, ... Molecules 22 (6), 1006, 2017 | 53 | 2017 |
| Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment Z Gazova, O Soukup, V Sepsova, K Siposova, L Drtinova, P Jost, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (2), 607-619, 2017 | 49 | 2017 |
| Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: A novel cholinesterase inhibitors for the treatment of Alzheimer’s disease K Spilovska, J Korabecny, A Horova, K Musilek, E Nepovimova, ... Medicinal Chemistry Research 24 (6), 2645-2655, 2015 | 41 | 2015 |
| Development of 2-Methoxyhuprine as Novel Lead for Alzheimer’s Disease Therapy E Mezeiova, J Korabecny, V Sepsova, M Hrabinova, P Jost, L Muckova, ... Molecules 22 (8), 1265, 2017 | 33 | 2017 |
| Tacrine and its derivatives in the therapy of Alzheimers disease J Korábečný, K Spilovska, O Benek, K Musilek, O Soukup, K Kuča Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2012 | 14 | 2012 |
| Intended pharmacotherapeutical approaches of Alzheimer's disease therapy J Korábecný, E Hruba, O Soukup, F Zemek, K Musilek, E Nepovimova, ... Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2012 | 5 | 2012 |
| Development of multi-target drugs for Alzheimer's disease based on acetylcholinesterasse inhibitors J Korabecny, O Soukup, J Ricny, K Spilovska, E Nepovimova, K Kuca JOURNAL OF NEUROCHEMISTRY 142, 213-213, 2017 | | 2017 |
| Alzheimer's Disease Drugs-In Vitro Comparison of Cholinesterase Inhibition and beta-amyloid Modulation O Holas, J Korabecny, Z Gazova, K Siposova, K Musilek, V Opletalova, ... Letters in Drug Design & Discovery 14 (6), 743-750, 2017 | | 2017 |
| Anti-amyloid activity of 7-MEOTA-Adamantylamine Heterodimers in the treatment of Alzheimert's disease K Siposova, O Soukup, V Sepsova, L Drtinova, K Spilovska, K Kuca, ... EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 44, S105-S105, 2015 | | 2015 |
| Interaction of 7-Methoxytacrine-Adamantylamine Cholinesterase Inhibitors with Nicotinic and Muscarinic Acetylcholine Receptors ZJ Wang, V Sepsova, K Spilovska, TS Mohamed, AK Hamouda Biophysical Journal 108 (2), 430a, 2015 | | 2015 |
